Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer

por van Nassau, Sietske C., Bond, Marinde J., Scheerman, Ilva, van Breeschoten, Jesper, Kessels, Rob, Valkenburg-van Iersel, Liselot B., Verheul, Henk M., Buffart, Tineke E., Mekenkamp, Leonie J., Lemmens, Valery E., Koopman, Miriam, Bol, Guus M.
Publicado 2021

Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer

por Graus, Merlijn U.J.E., de Hingh, Ignace H.J.T., Besselink, Marc G., Bruno, Marco J., Wilmink, Johanna W., de Meijer, Vincent E., van Velthuysen, Marie-Louise F., Valkenburg-van Iersel, Liselot B.J., van der Geest, Lydia G.M., de Vos-Geelen, Judith
Publicado 2023

Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer

por Heuvelings, Danique J. I., Wintjens, Anne G. W. E., Moonen, Laura, Engelen, Sanne M. E., de Hingh, Ignace H. J. T., Valkenburg-van Iersel, Liselot B., den Dulk, Marcel, Beckervordersandforth, Jan, Thijssen, Sharon G. M., Leunissen, Daphne J. G., Stassen, Laurents P. S., Keszthelyi, Daniel, Mujagic, Zlatan, Speel, Ernst-Jan M., Bouvy, Nicole D.
Publicado 2023

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma

por de Jong, Evelien J. M., Janssen, Quisette P., Simons, Tessa F. A., Besselink, Marc G., Bonsing, Bert A., Bouwense, Stefan A. W., Geurts, Sandra M. E., Homs, Marjolein Y. V., de Meijer, Vincent E., Tjan‐Heijnen, Vivianne C. G., van Laarhoven, Hanneke W. M., Valkenburg‐van Iersel, Liselot B. J., Wilmink, Johanna W., van der Geest, Lydia G., Koerkamp, Bas Groot, de Vos‐Geelen, Judith
Publicado 2021